Skip to main content

A novel role for cohesin-STAG2 in R loop homeostasis

NIGMS - National Institute of General Medical Sciences

open
OpenLast verified: 2026-07-14

About This Grant

PROJECT ABSTRACT In recent years, structural maintenance of chromosomes (SMC) complexes have emerged as critical ring-shaped and ATP-dependent DNA tethers and loop extruders. The most well-known SMC complex, cohesin, has vital importance in nearly all aspects of chromosome metabolism, including gene expression, nuclear architecture, DNA replication and repair, and mitotic chromosome segregation. Against this backdrop, large-scale cancer sequencing projects revealed frequent mutations in cohesin subunits in tumors at multiple organ sites. How these mutations promote cancer, and whether they create collateral vulnerabilities that could be targeted therapeutically, are important unsolved problems. Building on our previous studies of cohesin and DNA replication, we analyzed cells that lacked STAG2, the most frequently mutated cohesin subunit and a TCGA-designated pan-cancer driver. We discovered that STAG2-deficient cells are prone to accumulation of R-loops and experience all the hallmarks of replication stress. They are also “addicted” to R-loop mitigating factors, including RNAse H2 and the Fanconi Anemia pathway. Via NER endonucleases, STAG2-deficient cells produce cytoplasmic R-loop fragments that trigger innate immune signaling. We propose studies that will dissect the mechanisms that underlie R-loop homeostasis, gene regulation, and avoidance of replication-transcription conflicts. This information will expand and deepen our understanding of how STAG2 regulates the genome under normal conditions and how its loss impacts cancer cells. This information is needed to develop more effective and less toxic cancer therapies.

Grant Summary

A novel role for cohesin-STAG2 in R loop homeostasis is a NIGMS - National Institute of General Medical Sciences grant providing up to $535K for university, nonprofit, healthcare org. Applications are due 2030-01-31 (open). Check eligibility and apply with FindGrants.

Not quite the right fit?

Search 9,000+ open grants, or get matches ranked for your organization — free.

Focus Areas

health research

Eligibility

universitynonprofithealthcare org

How to Apply

Funding Range

Up to $535K

Deadline

2030-01-31

Complexity
High
  1. 1Confirm your organization is eligible for A novel role for cohesin-STAG2 in R loop homeostasis from NIGMS - National Institute of General Medical Sciences, checking organization type, location, and any population or project requirements.
  2. 2Gather the required documents and information, including your organization details, project plan, and budget figures.
  3. 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
  4. 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to NIGMS - National Institute of General Medical Sciences before the deadline.
This record is a past award, contract, or funder profile — useful for research, but not an open grant application. Check the original source for current opportunities from this funder.

Don't want to draft it yourself?

We'll draft the complete application against NIGMS - National Institute of General Medical Sciences's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.

AI Requirement Analysis

Detailed requirements not yet analyzed

Have the NOFO? Paste it below for AI-powered requirement analysis.

0 characters (min 50)

A novel role for cohesin-STAG2 in R loop homeostasis: Frequently Asked Questions

Who is eligible for the A novel role for cohesin-STAG2 in R loop homeostasis?

A novel role for cohesin-STAG2 in R loop homeostasis is offered by NIGMS - National Institute of General Medical Sciences and is generally open to university, nonprofit, healthcare org. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.

How much funding does the A novel role for cohesin-STAG2 in R loop homeostasis provide?

A novel role for cohesin-STAG2 in R loop homeostasis provides up to $535K per award from NIGMS - National Institute of General Medical Sciences. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.

When is the A novel role for cohesin-STAG2 in R loop homeostasis deadline?

Applications for A novel role for cohesin-STAG2 in R loop homeostasis are due 2030-01-31 (open). Because deadlines can change, verify the date with the funder, NIGMS - National Institute of General Medical Sciences, and give yourself enough time to prepare a complete, competitive application before the close date.

How do you apply for the A novel role for cohesin-STAG2 in R loop homeostasis?

To apply for A novel role for cohesin-STAG2 in R loop homeostasis, confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from NIGMS - National Institute of General Medical Sciences.